arXiv.itsnick.co

an independent field guide to 23 million papers from arXiv & OpenAlex — not affiliated with arXiv.org

Mathematics · Statistics and Probability

Subcutaneous Administration of Interleukin-2 and Interferon-alpha2b in Advanced Renal Cell Carcinoma: Long-Term Results

M.C. Locatelli, Giovanna Facendola, Giorgio Pizzocaro, Luigi Piva, Carlo Pegoraro, E. Bobbio Pallavicini, Signaroldi, Meregalli, Franco Lombardi, Giordano Beretta, F. Scanzi, Roberto Labianca

· Cancer Detection and Prevention

See on the map

Abstract

Clinical data have supported the combination of subcutaneous r-interleukin-2 (rIL-2) and r-interferon-alpha (rIFN-alpha) as a promising combination for advanced renal cell carcinoma (RCC), with a reduced toxicity. We evaluated the activity and safety of this outpatient immunotherapy and report on the clinical results and the long-term survival analysis. Objective responses was observed in 9 of 50 (18%) patients, 6 of whom (12%) achieved a complete response. Overall median survival is 12 months, six patients were surviving at a median follow-up of 24 months, and three (6%) are still progression-free.

More like this